Adverum Biotechnologies, Inc. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q2 2024.
  • Adverum Biotechnologies, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$20.9M, a 36.8% increase year-over-year.
  • Adverum Biotechnologies, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$108M, a 21.6% increase year-over-year.
  • Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2023 was -$124M, a 21.1% increase from 2022.
  • Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2022 was -$157M, a 7.54% decline from 2021.
  • Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2021 was -$146M, a 23.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$108M -$20.9M +$12.2M +36.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$121M -$26.8M +$3.4M +11.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$124M -$26.2M +$7.78M +22.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$132M -$34.5M +$6.51M +15.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$138M -$33.1M +$11M +24.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$149M -$30.2M +$7.89M +20.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$157M -$33.9M +$479K +1.39% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$158M -$41M -$2.52M -6.53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$155M -$44M +$513K +1.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$156M -$38.1M -$9.49M -33.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$146M -$34.4M +$1.96M +5.39% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$148M -$38.5M -$10.5M -37.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$138M -$44.5M -$14.8M -49.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$123M -$28.6M -$4.85M -20.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$118M -$36.4M -$16.7M -85.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$101M -$28M -$10.9M -63.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$90.3M -$29.8M -$13.7M -84.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$76.6M -$23.8M -$8.08M -51.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$68.5M -$19.7M -$2.89M -17.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$65.7M -$17.1M +$6.39M +27.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$72M -$16.1M +$3.8M +19.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$75.8M -$15.7M +$2.24M +12.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 -$78.1M -$16.8M -$1.16M -7.46% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$76.9M -$23.5M -$8.9M -61.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$68M -$19.9M -$7.81M -64.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$60.2M -$17.9M -$1.36M -8.19% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$58.8M -$15.6M +$7.79M +33.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$66.6M -$14.6M -$64K -0.44% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$66.6M -$12.1M +$49.8M +80.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$116M -$16.6M -$1.08M -6.96% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$115M -$23.4M -$9.21M -64.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$106M -$14.5M -$306K -2.16% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$106M -$61.9M -$52M -526% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$53.8M -$15.5M -$5.95M -62.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$47.8M -$14.2M -$3.78M -36.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$44M -$14.2M -$6.26M -78.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$37.8M -$9.88M -$5.43M -122% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$32.4M -$9.56M -$7.96M -495% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$24.4M -$10.4M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$7.94M -$7.16M -921% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$4.45M -$3.75M -532% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.61M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$778K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$705K Apr 1, 2013 Jun 30, 2013 10-Q 2014-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.